These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 10374418
1. Mixed connective tissue disease: a disease entity? Shen N, Chen S, Yang H, Fan L. Chin Med J (Engl); 1998 Mar; 111(3):214-7. PubMed ID: 10374418 [Abstract] [Full Text] [Related]
2. [Is mixed connective tissue disease a distinct rheumatic disease]. Chen S, Shen N, Yang H. Zhonghua Nei Ke Za Zhi; 1996 Oct; 35(10):694-7. PubMed ID: 9592332 [Abstract] [Full Text] [Related]
3. "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M. Semin Arthritis Rheum; 2012 Feb; 41(4):589-98. PubMed ID: 21959290 [Abstract] [Full Text] [Related]
4. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. Amigues JM, Cantagrel A, Abbal M, Mazieres B. J Rheumatol; 1996 Dec; 23(12):2055-62. PubMed ID: 8970041 [Abstract] [Full Text] [Related]
5. [Sharp's syndrome. Clinical, immunological and nosographic aspects]. Scagliusi P, Muratore M, Martiradonna A, Berlingerio G, Carrozzo M. Minerva Med; 1980 Dec 15; 71(50):3655-63. PubMed ID: 6161325 [Abstract] [Full Text] [Related]
6. [Systemic mixed connective tissue disease--Sharp's syndrome]. Dragicevic J, Drecun V, Mitrovic D, Jevtovic Dj, Bukilica M, Vucelja O. Srp Arh Celok Lek; 2001 Dec 15; 129(5-6):135-8. PubMed ID: 11797461 [Abstract] [Full Text] [Related]
7. [Clinical and serologic course of patients with mixed connective tissue disease]. López-Longo FJ, Fernández J, Monteagudo I, Rodríguez-Mahou M, Sánchez-Atrio AI, Pérez T, Escalona M, González CM, Lapointe N, Carreño L. Rev Clin Esp; 1994 Sep 15; 194(9):682-8. PubMed ID: 7984796 [Abstract] [Full Text] [Related]
8. [Sharp's syndrome (mixed connective tissue disease). Clinical aspects diagnosis and prognosis]. Rosenthal M, Müller W. Schweiz Med Wochenschr; 1977 Aug 20; 107(33):1162-5. PubMed ID: 197598 [Abstract] [Full Text] [Related]
9. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. Kotajima L, Aotsuka S, Sumiya M, Yokohari R, Tojo T, Kasukawa R. J Rheumatol; 1996 Jun 20; 23(6):1088-94. PubMed ID: 8782145 [Abstract] [Full Text] [Related]
10. MCTD: is it rare in India? Lawrence A, Aggarwal A, Misra R. Clin Rheumatol; 2007 Feb 20; 26(2):205-7. PubMed ID: 16598411 [Abstract] [Full Text] [Related]
11. [Isolated trigeminal neuropathy revealing the presence of Sharp's syndrome or MCTD (mixed connective tissue disease) (author's transl)]. Lagarde P, Lamotte-Barrillon S. Ann Med Interne (Paris); 1979 Feb 20; 130(6-7):337-41. PubMed ID: 227310 [Abstract] [Full Text] [Related]
12. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease. Salmhofer W, Hermann J, Joch M, Kerl H, Graninger W. J Eur Acad Dermatol Venereol; 2007 Sep 20; 21(8):1047-53. PubMed ID: 17714123 [Abstract] [Full Text] [Related]
13. [Nephropathy in patients with mixed connective tissue disease]. Yoshida A, Morozumi K, Takeda A, Koyama K. Ryumachi; 1994 Dec 20; 34(6):976-80. PubMed ID: 7863388 [Abstract] [Full Text] [Related]
14. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy]. Bodolay E, Szegedi G. Orv Hetil; 2002 Feb 03; 143(5):229-33. PubMed ID: 11875835 [Abstract] [Full Text] [Related]
15. [Mixed connective tissue disease--etiology, pathogenesis, clinical significance, treatment]. Zdrojewicz Z, Budzyń-Kozioł E, Puławska J. Postepy Hig Med Dosw; 1999 Feb 03; 53(5):751-66. PubMed ID: 10645148 [Abstract] [Full Text] [Related]
17. Mixed connective tissue disease: still crazy after all these years. Swanton J, Isenberg D. Rheum Dis Clin North Am; 2005 Aug 03; 31(3):421-36, v. PubMed ID: 16084316 [Abstract] [Full Text] [Related]
18. [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension]. Sasaki N, Kurose A, Inoue H, Sawai T. Ryumachi; 2002 Dec 03; 42(6):885-94. PubMed ID: 12632608 [Abstract] [Full Text] [Related]
19. Capillaroscopy is a dynamic process in mixed connective tissue disease. de Holanda Mafaldo Diógenes A, Bonfá E, Fuller R, Correia Caleiro MT. Lupus; 2007 Dec 03; 16(4):254-8. PubMed ID: 17439931 [Abstract] [Full Text] [Related]
20. Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease. Pallis M, Hopkinson N, Powell R. J Rheumatol; 1991 Oct 03; 18(10):1532-6. PubMed ID: 1765978 [Abstract] [Full Text] [Related] Page: [Next] [New Search]